SEARCH:   Advanced

Blood, 15 February 2006, Vol. 107, No. 4, pp. 1624-1626. Prepublished online as a Blood First Edition Paper on October 27, 2005; DOI 10.1182/blood-2005-05-2131. This Article Full Text (PDF) All Versions of this Article: 2005-05-2131v1 107/4/1624    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sudheendra, D. Articles by Wood, B. J Search for Related Content PubMed PubMed Citation Articles by Sudheendra, D. Articles by Wood, B. J Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted May 26, 2005 Accepted October 12, 2005 Radiofrequency ablation of lymphoma Deepak Sudheendra, Mara M Barth, Upendra Hegde, Wyndham H Wilson, and Bradford J Wood* Department of Radiology, National Institutes of Health, Bethesda, MD, USA Department of Radiology, Beth Israel Deaconness Medical Center, Boston, MA, USA Department of Hematology, University of Connecticut Health Center, Farmington, CT, USA Medicine Branch, National Cancer Institute, Bethesda, MD, USA * Corresponding author; email: bwood{at}nih.gov. Percutaneous minimally invasive radiofrequency (RF) ablation has not been described for lymphoma. This image-guided modality is presented in three different settings for the treatment of refractory lymphoma. The first patient received RF ablation for the curative treatment of a solitary residual hepatic mass following rituximab-based chemotherapy for a post-transplant lymphoproliferative disorder, and is disease-free four years later. The second patient received RF ablation for successful palliation of progressive follicular lymphoma adjacent to the bladder wall following chemotherapy and maximum radiation. The third patient received RF ablation for prevention of airway obstruction from progressive diffuse large B-cell lymphoma of the right neck following chemotherapy and maximum radiation. RF ablation may be clinically beneficial and should be considered for the treatment of local lymphoma that is refractory or not amenable to standard approaches. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020